E
BioNeutra Global Corporation
BGA.V
TSX
E
Sell
11/23/2022Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to E+ from D on 11/23/2022 due to a significant decline in the growth index, solvency index and total return index. Earnings per share declined from $0.002 to -$0.023, EBIT declined 260.51% from $225.9 to -$362.6, and the quick ratio declined from 0.24 to 0.13.
BioNeutra Global Corporation (BGA.V) was downgraded to E+ from D on 11/23/2022 due to a significant decline in the growth index, solvency index and total return index. Earnings per share declined from $0.002 to -$0.023, EBIT declined 260.51% from $225.9 to -$362.6, and the quick ratio declined from 0.24 to 0.13.
D
Sell
11/21/2022Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 11/21/2022 due to an increase in the volatility index and valuation index.
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 11/21/2022 due to an increase in the volatility index and valuation index.
D
Sell
11/3/2022Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 11/3/2022 due to a decline in the volatility index.
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 11/3/2022 due to a decline in the volatility index.
D
Sell
10/19/2022Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 10/19/2022 due to an increase in the volatility index and total return index.
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 10/19/2022 due to an increase in the volatility index and total return index.
D
Sell
10/4/2022Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 10/4/2022 due to a decline in the volatility index and valuation index.
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 10/4/2022 due to a decline in the volatility index and valuation index.
D
Sell
9/9/2022Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 9/9/2022 due to an increase in the volatility index.
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 9/9/2022 due to an increase in the volatility index.
D
Sell
8/19/2022Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 8/19/2022 due to a decline in the total return index and volatility index.
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 8/19/2022 due to a decline in the total return index and volatility index.
D
Sell
5/16/2022Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from E+ on 5/16/2022 due to an increase in the total return index.
BioNeutra Global Corporation (BGA.V) was upgraded to D from E+ on 5/16/2022 due to an increase in the total return index.
E
Sell
5/13/2022Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
BioNeutra Global Corporation (BGA.V) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/4/2022Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
BioNeutra Global Corporation (BGA.V) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
E
Sell
5/1/2022Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to E+ from D on 05/01/2022.
BioNeutra Global Corporation (BGA.V) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/29/2022Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from E+ on 4/29/2022 due to a major increase in the growth index, total return index and solvency index. Operating cash flow increased 602.71% from -$92.1 to $463, earnings per share increased from -$0.0159 to -$0.0105, and the quick ratio increased from 0.14 to 0.16.
BioNeutra Global Corporation (BGA.V) was upgraded to D from E+ on 4/29/2022 due to a major increase in the growth index, total return index and solvency index. Operating cash flow increased 602.71% from -$92.1 to $463, earnings per share increased from -$0.0159 to -$0.0105, and the quick ratio increased from 0.14 to 0.16.
E
Sell
11/29/2021Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to E+ from D- on 11/29/2021 due to a substantial decline in the growth index and solvency index. Earnings per share declined from -$0.0005 to -$0.0159, operating cash flow declined 112.81% from $719.2 to -$92.1, and debt to equity increased from -52.75 to -16.31.
BioNeutra Global Corporation (BGA.V) was downgraded to E+ from D- on 11/29/2021 due to a substantial decline in the growth index and solvency index. Earnings per share declined from -$0.0005 to -$0.0159, operating cash flow declined 112.81% from $719.2 to -$92.1, and debt to equity increased from -52.75 to -16.31.
D
Sell
11/23/2021Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D- from E+ on 11/23/2021 due to an increase in the total return index and valuation index.
BioNeutra Global Corporation (BGA.V) was upgraded to D- from E+ on 11/23/2021 due to an increase in the total return index and valuation index.
E
Sell
11/8/2021Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to E+ from D- on 11/8/2021 due to a decline in the volatility index, total return index and valuation index.
BioNeutra Global Corporation (BGA.V) was downgraded to E+ from D- on 11/8/2021 due to a decline in the volatility index, total return index and valuation index.
D
Sell
11/3/2021Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 11/3/2021 due to a significant decline in the solvency index, total return index and volatility index.
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 11/3/2021 due to a significant decline in the solvency index, total return index and volatility index.
D
Sell
1/20/2021Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 1/20/2021 due to an increase in the volatility index and total return index.
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 1/20/2021 due to an increase in the volatility index and total return index.
D
Sell
1/5/2021Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 1/5/2021 due to a decline in the total return index and volatility index.
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 1/5/2021 due to a decline in the total return index and volatility index.
D
Sell
12/21/2020Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 12/21/2020 due to an increase in the total return index and volatility index.
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 12/21/2020 due to an increase in the total return index and volatility index.
D
Sell
11/27/2020Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 11/27/2020 due to a decline in the growth index and solvency index. Earnings per share declined from $0.0026 to -$0.0011, EBIT declined 91.15% from -$176.3 to -$337, and operating cash flow declined 82.18% from $799 to $142.4.
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 11/27/2020 due to a decline in the growth index and solvency index. Earnings per share declined from $0.0026 to -$0.0011, EBIT declined 91.15% from -$176.3 to -$337, and operating cash flow declined 82.18% from $799 to $142.4.
D
Sell
10/9/2020Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 10/9/2020 due to an increase in the total return index and volatility index.
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 10/9/2020 due to an increase in the total return index and volatility index.
D
Sell
9/18/2020Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 9/18/2020 due to a decline in the total return index and growth index.
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 9/18/2020 due to a decline in the total return index and growth index.
D
Sell
9/3/2020Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 9/3/2020 due to an increase in the growth index. Earnings per share increased from -$0.018 to $0.0025, and EBIT increased 15.99% from -$103.2 to -$86.7.
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 9/3/2020 due to an increase in the growth index. Earnings per share increased from -$0.018 to $0.0025, and EBIT increased 15.99% from -$103.2 to -$86.7.
D
Sell
6/17/2020Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 6/17/2020 due to a large decline in the efficiency index, solvency index and growth index. EBIT declined 919.43% from -$539.3 to -$5.5M, earnings per share declined from -$0.0151 to -$0.0994, and net income declined 528.43% from -$691.8 to -$4.35M.
BioNeutra Global Corporation (BGA.V) was downgraded to D- from D on 6/17/2020 due to a large decline in the efficiency index, solvency index and growth index. EBIT declined 919.43% from -$539.3 to -$5.5M, earnings per share declined from -$0.0151 to -$0.0994, and net income declined 528.43% from -$691.8 to -$4.35M.
D
Sell
8/30/2019Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D from D+ on 8/30/2019 due to a substantial decline in the efficiency index, total return index and growth index. EBIT declined 22,937.3% from -$12.6 to -$2.9M, net income declined 309.57% from -$850.6 to -$3.48M, and earnings per share declined from -$0.0185 to -$0.0748.
BioNeutra Global Corporation (BGA.V) was downgraded to D from D+ on 8/30/2019 due to a substantial decline in the efficiency index, total return index and growth index. EBIT declined 22,937.3% from -$12.6 to -$2.9M, net income declined 309.57% from -$850.6 to -$3.48M, and earnings per share declined from -$0.0185 to -$0.0748.
D
Sell
5/31/2019Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D+ from C on 5/31/2019 due to a significant decline in the valuation index, volatility index and efficiency index. Net income declined 165.56% from $1.3M to -$850.6, and total capital declined 3.33% from $19.78M to $19.12M.
BioNeutra Global Corporation (BGA.V) was downgraded to D+ from C on 5/31/2019 due to a significant decline in the valuation index, volatility index and efficiency index. Net income declined 165.56% from $1.3M to -$850.6, and total capital declined 3.33% from $19.78M to $19.12M.
C
Hold
8/30/2018Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to C from D+ on 8/30/2018 due to a significant increase in the valuation index, efficiency index and total return index. Total capital increased 1.41% from $19.95M to $20.23M.
BioNeutra Global Corporation (BGA.V) was upgraded to C from D+ on 8/30/2018 due to a significant increase in the valuation index, efficiency index and total return index. Total capital increased 1.41% from $19.95M to $20.23M.
D
Sell
6/5/2018Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D+ from D on 6/5/2018 due to a noticeable increase in the efficiency index, volatility index and growth index. Earnings per share increased from $0.0157 to $0.028, net income increased 30.1% from $988 to $1.29M, and total revenue increased 23.29% from $6.32M to $7.79M.
BioNeutra Global Corporation (BGA.V) was upgraded to D+ from D on 6/5/2018 due to a noticeable increase in the efficiency index, volatility index and growth index. Earnings per share increased from $0.0157 to $0.028, net income increased 30.1% from $988 to $1.29M, and total revenue increased 23.29% from $6.32M to $7.79M.
D
Sell
5/16/2018Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D from D+ on 5/16/2018 due to a major decline in the valuation index, growth index and volatility index.
BioNeutra Global Corporation (BGA.V) was downgraded to D from D+ on 5/16/2018 due to a major decline in the valuation index, growth index and volatility index.
D
Sell
5/1/2018Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D+ from D on 5/1/2018 due to a major increase in the growth index, valuation index and solvency index. Earnings per share increased from -$0.0239 to $0.0528, EBIT increased 251.37% from -$782.6 to $1.18M, and operating cash flow increased 200.72% from $292.4 to $879.3.
BioNeutra Global Corporation (BGA.V) was upgraded to D+ from D on 5/1/2018 due to a major increase in the growth index, valuation index and solvency index. Earnings per share increased from -$0.0239 to $0.0528, EBIT increased 251.37% from -$782.6 to $1.18M, and operating cash flow increased 200.72% from $292.4 to $879.3.
D
Sell
11/28/2017Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D from D+ on 11/28/2017 due to a noticeable decline in the efficiency index, total return index and volatility index. Total capital declined 4.42% from $18.71M to $17.88M.
BioNeutra Global Corporation (BGA.V) was downgraded to D from D+ on 11/28/2017 due to a noticeable decline in the efficiency index, total return index and volatility index. Total capital declined 4.42% from $18.71M to $17.88M.
D
Sell
8/25/2017Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to D+ from C- on 8/25/2017 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0018 to -$0.0223, net income declined 1,246.42% from $85.3 to -$977.9, and EBIT declined 337.78% from $314.2 to -$747.1.
BioNeutra Global Corporation (BGA.V) was downgraded to D+ from C- on 8/25/2017 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0018 to -$0.0223, net income declined 1,246.42% from $85.3 to -$977.9, and EBIT declined 337.78% from $314.2 to -$747.1.
C
Hold
8/1/2017Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to C- from D+ on 8/1/2017 due to a substantial increase in the valuation index, efficiency index and volatility index. Total capital increased 1.81% from $19.18M to $19.53M.
BioNeutra Global Corporation (BGA.V) was upgraded to C- from D+ on 8/1/2017 due to a substantial increase in the valuation index, efficiency index and volatility index. Total capital increased 1.81% from $19.18M to $19.53M.
D
Sell
5/1/2017Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D+ from D on 5/1/2017 due to a substantial increase in the growth index, valuation index and volatility index. Earnings per share increased from $0.0003 to $0.0014.
BioNeutra Global Corporation (BGA.V) was upgraded to D+ from D on 5/1/2017 due to a substantial increase in the growth index, valuation index and volatility index. Earnings per share increased from $0.0003 to $0.0014.
D
Sell
11/1/2016Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 11/1/2016 due to a noticeable increase in the valuation index, growth index and efficiency index. Net income increased 312.02% from -$502.5 to $1.07M, earnings per share increased from -$0.0146 to $0.0232, and operating cash flow increased 252.37% from $111.9 to $394.3.
BioNeutra Global Corporation (BGA.V) was upgraded to D from D- on 11/1/2016 due to a noticeable increase in the valuation index, growth index and efficiency index. Net income increased 312.02% from -$502.5 to $1.07M, earnings per share increased from -$0.0146 to $0.0232, and operating cash flow increased 252.37% from $111.9 to $394.3.
D
Sell
7/1/2016Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to D- from E+ on 7/1/2016 due to an increase in the efficiency index. Total capital increased 0.48% from $17.51M to $17.6M.
BioNeutra Global Corporation (BGA.V) was upgraded to D- from E+ on 7/1/2016 due to an increase in the efficiency index. Total capital increased 0.48% from $17.51M to $17.6M.
E
Sell
5/12/2016Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to E+ from E on 5/12/2016 due to a noticeable increase in the growth index, valuation index and solvency index.
BioNeutra Global Corporation (BGA.V) was upgraded to E+ from E on 5/12/2016 due to a noticeable increase in the growth index, valuation index and solvency index.
E
Sell
4/27/2016Downgrade
BioNeutra Global Corporation (BGA.V) was downgraded to E from E+ on 4/27/2016 due to a decline in the valuation index and growth index. EBIT declined 235.82% from -$214.7 to -$721.
BioNeutra Global Corporation (BGA.V) was downgraded to E from E+ on 4/27/2016 due to a decline in the valuation index and growth index. EBIT declined 235.82% from -$214.7 to -$721.
E
Sell
4/1/2016Upgraded
BioNeutra Global Corporation (BGA.V) was upgraded to E+ from E on 4/1/2016 due to a significant increase in the total return index.
BioNeutra Global Corporation (BGA.V) was upgraded to E+ from E on 4/1/2016 due to a significant increase in the total return index.
E
Sell
1/20/2016None
BioNeutra Global Corporation (BGA.V) was downgraded to E from U on 01/20/2016.
BioNeutra Global Corporation (BGA.V) was downgraded to E from U on 01/20/2016.
